This observation provided additional support to suggest that increased activated CD8+ and CD4+T lymphocytes in the tumor microenvironment may play an important role in improved LT survival outcome in HGSOC (Additional file 1: Figure S11). The gene discussed is CD4; the disease is neoplasm.